BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21616914)

  • 1. Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials.
    Heijl C; Harper L; Flossmann O; Stücker I; Scott DG; Watts RA; Höglund P; Westman K; Mahr A;
    Ann Rheum Dis; 2011 Aug; 70(8):1415-21. PubMed ID: 21616914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Malignancies in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Diagnosed Between 1991 and 2013.
    Rahmattulla C; Berden AE; Wakker SC; Reinders ME; Hagen EC; Wolterbeek R; Bruijn JA; Bajema IM
    Arthritis Rheumatol; 2015 Dec; 67(12):3270-8. PubMed ID: 26246307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.
    Faurschou M; Sorensen IJ; Mellemkjaer L; Loft AG; Thomsen BS; Tvede N; Baslund B
    J Rheumatol; 2008 Jan; 35(1):100-5. PubMed ID: 17937462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged risk of specific malignancies following cyclophosphamide therapy among patients with granulomatosis with polyangiitis.
    Faurschou M; Mellemkjaer L; Voss A; Keller KK; Hansen IT; Baslund B
    Rheumatology (Oxford); 2015 Aug; 54(8):1345-50. PubMed ID: 25234661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis.
    van Daalen EE; Rizzo R; Kronbichler A; Wolterbeek R; Bruijn JA; Jayne DR; Bajema IM; Rahmattulla C
    Ann Rheum Dis; 2017 Jun; 76(6):1064-1069. PubMed ID: 27899372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis.
    Mahr A; Katsahian S; Varet H; Guillevin L; Hagen EC; Höglund P; Merkel PA; Pagnoux C; Rasmussen N; Westman K; Jayne DR;
    Ann Rheum Dis; 2013 Jun; 72(6):1003-10. PubMed ID: 22962314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Malignancy Prior to Antineutrophil Cytoplasmic Antibody-associated Vasculitis Compared to the General Population.
    van Daalen EE; Rahmattulla C; Wolterbeek R; Bruijn JA; Bajema IM
    J Rheumatol; 2017 Mar; 44(3):314-318. PubMed ID: 28089971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.
    Suppiah R; Hadden RD; Batra R; Arden NK; Collins MP; Guillevin L; Jayne DR; Luqmani RA;
    Rheumatology (Oxford); 2011 Dec; 50(12):2214-22. PubMed ID: 21890618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief Report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
    Faurschou M; Westman K; Rasmussen N; de Groot K; Flossmann O; Höglund P; Jayne DR;
    Arthritis Rheum; 2012 Oct; 64(10):3472-7. PubMed ID: 22614882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineutrophil cytoplasmic antibody-associated vasculitis and malignancy.
    Wester Trejo MAC; Bajema IM; van Daalen EE
    Curr Opin Rheumatol; 2018 Jan; 30(1):44-49. PubMed ID: 28957961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignancies in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis: A Population-based Cohort Study.
    Heijl C; Westman K; Höglund P; Mohammad AJ
    J Rheumatol; 2020 Aug; 47(8):1229-1237. PubMed ID: 31474595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive pulmonary aspergillosis in patients with antineutrophil cytoplasmic antibody associated vasculitis.
    Su T; Li HC; Chen M; Gao L; Zhou FD; Wang RG; Zhang H; Li XM; Zhao MH
    J Clin Rheumatol; 2009 Dec; 15(8):380-2. PubMed ID: 19279506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer development in Korean patients with ANCA-associated vasculitis: a single centre study.
    Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):73-77. PubMed ID: 29465366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Jayne D; Rasmussen N; Andrassy K; Bacon P; Tervaert JW; Dadoniené J; Ekstrand A; Gaskin G; Gregorini G; de Groot K; Gross W; Hagen EC; Mirapeix E; Pettersson E; Siegert C; Sinico A; Tesar V; Westman K; Pusey C;
    N Engl J Med; 2003 Jul; 349(1):36-44. PubMed ID: 12840090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term patient survival in ANCA-associated vasculitis.
    Flossmann O; Berden A; de Groot K; Hagen C; Harper L; Heijl C; Höglund P; Jayne D; Luqmani R; Mahr A; Mukhtyar C; Pusey C; Rasmussen N; Stegeman C; Walsh M; Westman K;
    Ann Rheum Dis; 2011 Mar; 70(3):488-94. PubMed ID: 21109517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
    Pagnoux C; Mahr A; Hamidou MA; Boffa JJ; Ruivard M; Ducroix JP; Kyndt X; Lifermann F; Papo T; Lambert M; Le Noach J; Khellaf M; Merrien D; Puéchal X; Vinzio S; Cohen P; Mouthon L; Cordier JF; Guillevin L;
    N Engl J Med; 2008 Dec; 359(26):2790-803. PubMed ID: 19109574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
    Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
    Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of cancer in a cohort of patients with primary Sjogren's syndrome.
    Lazarus MN; Robinson D; Mak V; Møller H; Isenberg DA
    Rheumatology (Oxford); 2006 Aug; 45(8):1012-5. PubMed ID: 16490754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of Cancer in ANCA-Associated Vasculitis: A Meta-Analysis of Observational Studies.
    Shang W; Ning Y; Xu X; Li M; Guo S; Han M; Zeng R; Ge S; Xu G
    PLoS One; 2015; 10(5):e0126016. PubMed ID: 25973882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
    Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
    Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.